Home

Transforming Healthcare with Evidence

hayesinfo@hayesinc.com | 215-855-0615




Their Directory and additional products have played an important role in the development of our own medical policies.

Michael M. Siegel, MD
Molina Healthcare, Inc.

Hayes CEO to speak at 2008 Healthcare Executive Summit

Tuesday, December 18th, 2007

LANSDALE, Pa. — December 18, 2007 — Winifred S. Hayes, PhD, CEO of Hayes, Inc., will speak about the role of evidence in strategic medical technology planning at the Connecticut Hospital Association’s 2008 Healthcare Executive Summit on January 29 in Wallingford, CT. Her presentation is scheduled for 10:00 – 11:00 am.

Dr. Hayes’ topic will cover the process of health technology assessment (HTA) and its role in healthcare decision making. She will address the importance of combining horizon scanning and HTA in identifying emerging technologies and evaluating their potential impact, ultimately improving the strategic technology planning process.

Connecticut Hospital Association provides a number of educational programs devoted to critical issues for healthcare leaders, and Hayes, Inc. is a sponsor of the 2008 Summit. For additional information about the event, visit http://www.cthosp.org/Education/Education.asp.

Dr. Hayes has published articles in both peer-reviewed medical journals and major healthcare publications, and is a frequent speaker at healthcare conferences. Her clinical experience includes trauma, critical care, acute care, occupational health, and ambulatory care. Dr. Hayes serves on the Board of Directors for URAC, a nonprofit healthcare accreditation and certification organization. She is also a member of Health Technology Assessment International, Women Business Leaders of the U.S. Health Care Industry Foundation, and Vistage (formerly TEC), an international organization of CEOs dedicated to increasing the effectiveness of chief executives and those they influence.

About Hayes
Hayes, Inc. is an independent health technology assessment (HTA) company. Its products and services are targeted primarily at healthcare professionals and decision makers working in policy and management positions. Hayes identifies and monitors new and emerging technologies likely to have a significant impact on the cost, utilization, and quality of healthcare. Its assessments provide information on the safety, efficacy, and cost-effectiveness of these technologies, including medical and surgical procedures, drugs, biologics, diagnostic and screening tests, medical devices and equipment, and complementary and alternative therapies. Hayes has no ties to manufacturers or any organization standing to benefit from the sale or use of a particular technology, and its information supports decision-making in coverage policy, contracting, acquisition, and health technology deployment. In addition, Hayes offers a variety of custom, consulting, and educational services. For more information, visit www.hayesinc.com.

You have received this message because your company subscribes to our products or you are listed in our media database. If you no longer wish to receive our press releases, please click here. Or, print this e-mail and send it with your name and e-mail address to the location listed below. We will remove you from our mailing list within five (5) business days.

Hayes, Inc. Client Services
157 S. Broad Street
Lansdale, PA 19446

Contact:
Rosemarie Jennings
215.855.0615, ext.346
rjennings@hayesinc.com

 

NEW CPT Codes for Molecular Tests

NEW CPT Codes for Molecular Tests

Social Media

More

Stay Connected!

To receive email newsletters, updates, and special offers from Hayes, enter your email and press Submit.
Email